Follow-up of retinoblastoma patients having prenatal and perinatal predictions for mutant gene carrier status using intragenic polymorphic probes from the RB1 gene
1992

Genetic Screening for Retinoblastoma

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Z. Onadim, J. Hungerford, J.K. Cowell

Primary Institution: ICRF Oncology Group, Institute of Child Health

Hypothesis

Can prenatal and perinatal genetic screening accurately predict mutant gene carrier status in retinoblastoma patients?

Conclusion

The study found that only one out of ten patients inherited the mutant gene, indicating that repeated screening for those who do not carry the gene is unnecessary.

Supporting Evidence

  • Only one patient inherited the mutant gene out of ten tested.
  • Six patients reached an age where tumors would typically develop and remained disease-free.
  • Standard linkage studies were employed using intragenic DNA probes.

Takeaway

This study looked at families with a history of a childhood eye cancer called retinoblastoma and found that most kids didn't inherit the gene that causes it, so they don't need to be checked for it again.

Methodology

The study used standard linkage studies with intragenic DNA probes to analyze genetic samples from patients and their families.

Limitations

The study's sample size was small, and the families were not randomly selected, which may affect the generalizability of the results.

Participant Demographics

The study involved ten individuals with a family history of retinoblastoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication